Retaining hard-to-reach women in HIV prevention and vaccine trials: Project ACHIEVE

American Journal of Public Health

Volumn 91, Issue 9, 2001, Pages 1377-1379

  Brown Peterside, P ^a   Rivera, E ^a   Lucy, D ^a   Slaughter, I ^a   Ren, L ^a   Chiasson, M A ^a   Koblin, B A ^a  

^a NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; PATIENT COMPLIANCE; PATIENT COUNSELING; PRACTICE GUIDELINE; PUBLIC HEALTH SERVICE; RESIDENTIAL CARE; SOCIAL WORK;

EID: 0034862183     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.91.9.1377     Document Type: Article

References (7)

1. A perspective on AIDS vaccines
2. Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States
3. Feasibility of conducting HIV-1 vaccine trials in the United States: Recruitment, retention and HIV-1 seroincidence from the HIV Network for Prevention Trials (HIVNET) Vaccine Preparedness Study (VPS)
4. Reframing women's risk: Social inequalities and HIV infection
5. Enabling women to participate in HIV vaccine efficacy trials: Lessons learned from a US vaccine preparedness study
6. Involving women in HIV vaccine efficacy trials: Lessons learned from a vaccine preparedness study in New York City
7. Retaining and tracking cohort study members